BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15845431)

  • 1. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection.
    Visnegarwala F; Chen L; Raghavan S; Tedaldi E
    J Infect; 2005 May; 50(4):331-7. PubMed ID: 15845431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors.
    Jain MK; Aragaki C; Fischbach L; Gibson S; Arora R; May L; Vardhineni K; Lee WM
    HIV Med; 2007 Nov; 8(8):491-7. PubMed ID: 17944681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection.
    Poussier A; Lebouvier M; Penfornis A; Di Martino V; Buffier P; Verges B; Hillon P; Petit JM
    Diabet Med; 2008 Oct; 25(10):1237-40. PubMed ID: 19046205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naïve patients is associated with renal insufficiency and increased mortality.
    Parboosing R; Paruk I; Lalloo UG
    J Med Virol; 2008 Sep; 80(9):1530-6. PubMed ID: 18649335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study.
    Squillace N; Lapadula G; Torti C; Orlando G; Mandalia S; Nardini G; Beghetto B; Costarelli S; Guaraldi G
    HIV Med; 2008 Mar; 9(3):151-9. PubMed ID: 18218000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of type 2 diabetes mellitus in Brazilian liver transplant candidates: negative association with HCV status.
    Parolin MB; Zaina FE; Araújo MV; Kupka E; Coelho JC
    Transplant Proc; 2004 Nov; 36(9):2774-5. PubMed ID: 15621146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
    Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
    Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hepatitis C, diabetes mellitus, and race. a case-control study.
    Thuluvath PJ; John PR
    Am J Gastroenterol; 2003 Feb; 98(2):438-41. PubMed ID: 12591065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection, increased serum ferritin and hyperinsulinemia.
    Garrido Serrano A; Guerrero Igea FJ; Lepe Jiménez JA; Palomo Gil S; Grilo Reina A
    Rev Esp Enferm Dig; 2001 Oct; 93(10):639-48. PubMed ID: 11767488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study.
    Zein CO; Levy C; Basu A; Zein NN
    Am J Gastroenterol; 2005 Jan; 100(1):48-55. PubMed ID: 15654780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of new-onset diabetes mellitus in Brazilian liver transplant recipients: association with HCV infection.
    Parolin MB; Zaina FE; Araújo MV; Kupka E; Coelho JC
    Transplant Proc; 2004 Nov; 36(9):2776-7. PubMed ID: 15621147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohort.
    Bénet T; D'Oliveira A; Voirin N; Livrozet JM; Cotte L; Peyramond D; Chidiac C; Touraine JL; Fabry J; Trepo C; Allard R; Vanhems P
    J Viral Hepat; 2007 Oct; 14(10):730-5. PubMed ID: 17875008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication.
    Huang JF; Dai CY; Hwang SJ; Ho CK; Hsiao PJ; Hsieh MY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Shin SJ; Chang WY; Chuang WL; Yu ML
    Am J Gastroenterol; 2007 Jun; 102(6):1237-43. PubMed ID: 17531012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy.
    Palacios R; Merchante N; Macias J; González M; Castillo J; Ruiz J; Márquez M; Gómez-Mateos J; Pineda JA; Santos J
    Antivir Ther; 2006; 11(4):529-35. PubMed ID: 16856627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.